|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.70 HKD | +2.07% |
|
+0.39% | +6.48% |
| 12-03 | Shanghai Henlius Biotech, Inc. Renewal of the Sinopharm Distribution Agreement | CI |
| 11-28 | Sinopharm Group Co. Ltd. Announces Board and Committee Resignations | CI |
| Capitalization | 56.52B 63.29B 8.12B 6.97B 6.47B 6.04B 11.25B 738B 12.09B 74.74B 29.44B 351B 30.44B 29.81B 1,283B | P/E ratio 2025 * |
7.67x | P/E ratio 2026 * | 6.78x |
|---|---|---|---|---|---|
| Enterprise value | 57.21B 64.06B 8.22B 7.06B 6.55B 6.12B 11.39B 747B 12.24B 75.65B 29.79B 355B 30.81B 30.18B 1,299B | EV / Sales 2025 * |
0.1x | EV / Sales 2026 * | 0.09x |
| Free-Float |
42.99% | Yield 2025 * |
3.93% | Yield 2026 * | 4.25% |
| 25/08/25 | Sinopharm : 2025 Interim Results Presentation | PU |
| 24/03/25 | Sinopharm : 2024 Annual Results Presentation | PU |
| 25/09/24 | Sinopharm : 2024 Interim Report | PU |
| 26/08/24 | Sinopharm : 2024 Interim Results Presentation | PU |
| 28/08/23 | Sinopharm : 2023 Interim Results Presentation | PU |
| 1 day | +1.87% | ||
| 1 week | +0.19% | ||
| Current month | +6.28% | ||
| 1 month | +4.08% | ||
| 3 months | +10.42% | ||
| 6 months | +10.01% | ||
| Current year | +6.28% |
| 1 week | 20.24 |  | 20.98 |
| 1 month | 19.29 | | 20.98 |
| Current year | 19.31 | | 20.98 |
| 1 year | 16.74 | | 21.66 |
| 3 years | 16.02 | | 28.45 |
| 5 years | 14.6 | | 28.45 |
| 10 years | 14.6 | | 45.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wan Yong Lian
PSD | President | 56 | 26/08/2024 |
Yi Jian Wu
SEC | Corporate Secretary | 56 | - |
Xiu Chang Jiang
DFI | Director of Finance/CFO | 62 | 30/04/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 53 | 30/04/2010 |
Zheng Dong Liu
BRD | Director/Board Member | 56 | 20/09/2014 |
De Yong Wen
BRD | Director/Board Member | 54 | 31/08/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -19.71% | 1.36% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.78% | +0.19% | +3.61% | +7.49% | 8.12B | |
| -0.43% | +1.80% | +41.83% | +121.92% | 104B | |
| -0.47% | +4.90% | +68.25% | +181.47% | 50.48B | |
| +1.74% | +0.69% | - | - | 22.16B | |
| -0.54% | -2.40% | +17.46% | -20.26% | 9.67B | |
| -0.23% | -3.35% | -10.54% | -6.98% | 8.32B | |
| -5.29% | +0.09% | +10.15% | +68.97% | 6.61B | |
| -0.51% | +0.46% | +24.59% | +32.43% | 6.11B | |
| +0.19% | -0.57% | +6.91% | +3.69% | 3.77B | |
| Average | -0.41% | -0.11% | +20.28% | +48.59% | 24.33B | |
| Weighted average by Cap. | -0.27% | +2.24% | +41.35% | +113.22% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 588B 659B 84.48B 72.56B 67.32B 62.9B 117B 7,676B 126B 778B 306B 3,655B 317B 310B 13,356B | 619B 693B 88.83B 76.3B 70.8B 66.14B 123B 8,072B 132B 818B 322B 3,843B 333B 326B 14,045B |
| Net income | 7.34B 8.22B 1.05B 905M 840M 785M 1.46B 95.75B 1.57B 9.7B 3.82B 45.59B 3.95B 3.87B 167B | 8.23B 9.21B 1.18B 1.01B 941M 880M 1.64B 107B 1.76B 10.88B 4.28B 51.11B 4.43B 4.34B 187B |
| Net Debt | 689M 772M 98.97M 85.01M 78.87M 73.69M 137M 8.99B 147M 911M 359M 4.28B 371M 364M 15.65B | 1.34B 1.5B 192M 165M 153M 143M 266M 17.45B 286M 1.77B 696M 8.31B 720M 705M 30.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/01/26 | 20.70 $ | +2.07% | 5,354,298 |
| 19/01/26 | 20.28 $ | -1.65% | 5,381,970 |
| 16/01/26 | 20.62 $ | +0.88% | 3,609,445 |
| 15/01/26 | 20.44 $ | -0.58% | 4,022,424 |
| 14/01/26 | 20.56 $ | -0.39% | 2,976,324 |
Delayed Quote Hong Kong S.E., January 20, 2026 at 07:36 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1099 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition